RecruitingNot ApplicableNCT01945840
Gut Hormones and Roux en Y Gastric Bypass
Do Gut Hormones Mediate the Beneficial Effects of Roux-en-Y Bypass?
Sponsor
Imperial College London
Enrollment
190 participants
Start Date
Oct 1, 2013
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess whether the changes in gut hormones seen following Roux en Y Gastric Bypass surgery are responsible for some of the beneficial effects seen post-operatively.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Plain Language Summary
Simplified for easier understanding
This study is examining how gut hormones (the chemical messengers produced in your digestive system) change after a type of weight-loss surgery called Roux-en-Y gastric bypass, to better understand why this surgery helps control blood sugar in people with type 2 diabetes.
**You may be eligible if...**
- You are scheduled for or have recently had Roux-en-Y gastric bypass surgery
- You have been diagnosed with obesity (body mass index above a certain level)
- You may or may not have type 2 diabetes
- You are between 18 and 65 years old
- You are willing to attend study visits and provide blood samples at multiple time points
**You may NOT be eligible if...**
- You have had prior stomach or intestinal surgery (other than the gastric bypass being studied)
- You have serious kidney, liver, or heart disease
- You are pregnant or planning to become pregnant during the study
- You are using certain medications that affect blood sugar or gut hormones
- You have type 1 diabetes
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURERoux en Y Gastric Bypass Surgery
OTHERGut hormone infusion
OTHERPlacebo infusion
OTHERVery low calorie diet
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01945840
Related Trials
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
NCT074073481 location
Situation and Evolution of the Misuse of Alcohol and Other Addictive Behaviors in Obese Patients Being Managed at Nîmes University Hospital
NCT046137911 location
PRImary Care Strategies for Weight Management (PRISM) Study
NCT072882941 location
Body Composition Outcomes in MS Patients
NCT075307182 locations
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
NCT072258161 location